A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India

A prospective observational safety study on ChAdOx1 nCoV-19 corona virus vaccine (recombinant) use in healthcare workers- first results from India

Background: We provide the first post-approval safety analysis of COVISHIELD in health care workers (HCWs) in northern India. Methods: This continuing prospective observational study (February 2021 to May 2022) enrolled participants ≥18 years receiving COVISHIELD vaccination. Primary outcome was saf...

Full description

Bibliographic Details
Main Authors: Upinder Kaur, Bisweswar Ojha, Bhairav Kumar Pathak, Anup Singh, Kiran R. Giri, Amit Singh, Agniva Das, Anamika Misra, Ashish Kumar Yadav, Sangeeta Kansal, Sankha Shubhra Chakrabarti
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:EClinicalMedicine
Subjects:
Post-approval
AEFI
India
Risk
Thyroid
COVID-19
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537021003187

Internet

http://www.sciencedirect.com/science/article/pii/S2589537021003187

Similar Items